Cytotoxic activity of gonadotropin-releasing hormone (GnRH)-pokeweed antiviral protein conjugates in cell lines expressing GnRH receptors

Endocrinology

Volumn 144, Issue 4, 2003, Pages 1456-1463

  Yang, Wei Hsiung ^a   Wieczorck, Maciej ^a   Allen, Matt C ^a   Nett, Terry M ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GONADORELIN DERIVATIVE; GONADORELIN RECEPTOR; GONADORELIN[6 DEXTRO LYSINE 9 PROLINE] ETHYLAMIDE; HORMONOTOXIN; POKEWEED ANTIVIRUS PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CHO CELL; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DOSE RESPONSE; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG EFFECT; ENDOMETRIUM CANCER; GENETIC TRANSFECTION; GONADOTROPIN SECRETING CELL; HORMONAL CONTRACEPTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PLANT LEAF; POKEWEED; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN ISOLATION; RECEPTOR DENSITY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CATTLE; CHO CELLS; CRICETINAE; GENE EXPRESSION; GONADOTROPIN-RELEASING HORMONE; HUMANS; N-GLYCOSYL HYDROLASES; PLANT PROTEINS; PROTEIN BIOSYNTHESIS; RECEPTORS, LHRH; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0037390439     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2002-220917     Document Type: Article

References (50)

1. Pastan I, Fitzgerald DJ 1991 Recombinant toxins for cancer treatment. Science 254:1173-1177
2. Pincus SH 1996 Therapeutic potential of anti-HIV immunotoxins. Antivir Res 33:1-9
3. Chang TM, Dazord A, Neville DM 1977 Artificial hybrid protein containing a toxic protein fragment and a cell membrane receptor-binding moiety in a disulfide conjugate. II. Biochemical and biologic properties of diphtheria toxin fragment A-S-S-human placental lactogen. J Biol Chem 252:1515-1522
4. Myers DA, Villemez CL 1989 A superactive hormonotoxin prepared with truncated diphtheria toxin. Biochem Biophys Res Commun 163:161-164
5. Pai LH, Batra JK, Fitzgerald DJ, Willingham MC, Pastan I 1992 Antitumor effects of B3-PE and B3-LysPE40 in a nude mouse model of human breast cancer and the evaluation of B3-PE toxicity in monkeys. Cancer Res 52:3189-3193
6. Brinkmann U, Pastan I 1994 Immunotoxins against cancer. Biochim Biophys Acta 1198:27-45
7. Godal A, Fodstad O, Pihl A 1983 Antibody formation against the cytotoxic proteins abrin and ricin in humans and mice. Int J Cancer 32:515-521
8. Irvin JD, Uckun FM 1992 Pokeweed antiviral protein: ribosome inactivation and therapeutic applications. Pharmacol Ther 55:279-302
9. Endo Y, Mitsui K, Motizuki M, Tsurugi K 1987 The mechanism of action of ricin and related toxins on eukaryotic ribosomes. The site and the characteristics of the modification in 28 S ribosomal RNA caused by the toxins. J Biol Chem 262:5908-5912
10. Endo Y, Tsurugi K 1987 RNA N-glycosidase activity of ricin A-chain. Mechanism of action of the toxic lectin ricin on eukaryotic ribosomes. J Biol Chem 262:8128-8130
11. Endo Y, Tsurugi K, Lambert JM 1988 The site of action of six different ribosome-inactivating proteins from plants on eukaryotic ribosomes: the RNA N-glycosidase activity of the proteins. Biochem Biophys Res Commun 150: 1032-1036
12. Hartley MR, Legname G, Osborn R, Chen Z, Lord JM 1991 Single-chain ribosome inactivating proteins from plants depurinate Escherichia coli 23S ribosomal RNA. FEBS Lett 290:65-68
13. Gessner SL, Irvin JD 1980 Inhibition of elongation factor 2-dependent translocation by the pokeweed antiviral protein and ricin. J Biol Chem 255:3251-3253
14. Hudak KA, Dinman JD, Tumer NE 1999 Pokeweed antiviral protein accesses ribosomes by binding to L3. J Biol Chem 274:3859-3864
15. Stirpe F, Barbieri L, Battelli MG, Soria M, Lappi DA 1992 Ribosome-inactivating proteins from plants: present status and future prospects. Biotechnology 10:405-412
16. Hubbard SC, Kranz DM, Longmore GD, Sitkovsky MV, Eisen HN 1986 Glycosylation of the T-cell antigen-specific receptor and its potential role in lectin-mediated cytotoxicity. Proc Natl Acad Sci USA 83:1852-1856
17. Li BY, Frankel AE, Ramakrishnan S 1992 High-level expression and simplified purification of recombinant ricin A chain. Protein Expr Purif 3:386-394
18. Barbieri L, Battelli MG, Stripe F 1993 Ribosome-inactivating proteins from plants. Biochim Biophys Acta 1154:237-282
19. Denis L, Mahler C 1990 Prostatic cancer: an overview. Acta Oncol 29:665-677
20. D'Cruz OJ, Uckun FM 2001 Pokeweed antiviral protein: a potential nonspermicidal prophylactic antiviral agent. Fertil Steril 75:106-114
21. Uckun FM, Gajl-Peczalska KJ, Kersey JH, Houston LL, Vallera DA 1986 Use of a novel colony assay to evaluate the cytotoxicity of an immunotoxin containing pokeweed antiviral protein against blast progenitor cells freshly obtained from patients with common B-lineage acute lymphoblastic leukemia. J Exp Med 163:347-368
22. Myers DE, Irvin JD, Smith RS, Kuebelbeck VM, Uckun FM 1991 Production of a pokeweed antiviral protein (PAP)-containing immunotoxin, B43-PAP, directed against the CD19 human B lineage lymphoid differentiation antigen in highly purified form for human clinical trials. J Immunol Methods 136: 221-238
23. Jansen B, Uckun FM, Jaszcz WB, Kersey JH 1992 Establishment of a human t(4;11) leukemia in severe combined immunodeficient mice and successful treatment using anti-CD19 (B43)-pokeweed antiviral protein immunotoxin. Cancer Res 52:406-412
24. Nicholson RI, Walker KJ 1989 GnRH agonists in breast and gynaecologic cancer treatment. J Steroid Biochem 33:801-804
25. Vickery BH 1986 Comparison of the potential for therapeutic utilities with gonadotropin-releasing hormone agonists and antagonists. Endocr Rev 7: 115-124
26. Hoffken K 1992 LH-RH agonists in the treatment of premenopausal patients with advanced breast cancer. Recent Results Cancer Res 124:91-104
27. Weinbauer GF, Nieschlag E 1992 LH-RH antagonists: state of the art and future perspectives. Recent Results Cancer Res 124:113-136
28. Miller WR, Scott WN, Morris R, Fraser HM, Sharpe RM 1985 Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist. Nature 313:231-233
29. Eidne KA, Flanagan CA, Harris NS, Millar RP 1987 Gonadotropin-releasing hormone (GnRH)-binding sites in human breast cancer cell lines and inhibitory effects of GnRH antagonists. J Clin Endocrinol Metab 64:425-432
30. Jennes L, Dalati B, Conn PM 1988 Distribution of gonadotropin-releasing hormone agonist binding sites in the rat central nervous system. Brain Res 452:156-164
31. Qayum A, Gullick W, Clayton RC, Sikora K, Waxman J 1990 The effects of gonadotrophin releasing hormone analogues in prostate cancer are mediated through specific tumour receptors. Br J Cancer 62:96-99
32. Emons G, Ortmann O, Becker M, Irmer G, Springer B, Laun R, Holzel F, Schulz KD, Schally AV 1993 High affinity binding and direct antiproliferative effects of LH-RH analogs in human ovarian cancer cell lines. Cancer Res 53:5439-5446
33. Imai A, Ohno T, Lida K, Fuseya T, Furui T, Tamaya T 1994 Presence of gonadotropin-releasing hormone receptor and its messenger ribonucleic acid in endometrial carcinoma and endometrium. Gynecol Oncol 55:144-148
34. Palyi I, Vincze B, Lovas S, Mezo I, Pato J, Kalnay A, Turi G, Gaal D, Mihalik R, Peter I, Teplan I, Murphy RF 1999 Gonadotropin-releasing hormone analogue conjugates with strong selective antitumor activity. Proc Natl Acad Sci USA 96:2361-2366
35. Irvin JD 1983 Pokeweed antiviral protein. Pharmacol Ther 21:371-387
36. Wagner TOF, Adams TE, Nett TM 1979 GnRH interaction with anterior pituitary. I. Determination of the affinity and number of receptors for GnRH in ovine anterior pituitary. Biol Reprod 20:140-149
37. Nelson S, Horvat RD, Malvey J, Roess DA, Barisas BG, Clay CM 1999 Characterization of an intrinsically fluorescent gonadotropin-releasing hormone receptor and effects of ligand binding on receptor lateral diffusion. Endocrinology 140:950-957
38. Hashizume T, Yang WH, Clay CM, Nett TM 2001 Internalization rates of murine and ovine gonadotropin-releasing hormone receptors. Biol Reprod 64:898-903
39. Kaiser UB, Conn PM, Chin WW 1997 Studies of gonadotropin-releasing hormone (GnRH) action using GnRH receptor-expressing pituitary cell lines. Endocr Rev 18:46-70
40. Palyi I, Vincze B, Kalnay A, Turi G, Mezo I, Teplan I, Seprodi J, Pato J, Mora M 1996 Effect of GnRH analogs and their conjugates on GnRH receptor-positive human cancer cell lines. Cancer Detect Prevent 20:146-152
41. SAS. SAS/STAT User's Guide (ed 6.03). Cary, NC: Statistical Analysis System Institute Inc.; 1988
42. Schlick JL, Dulieu P, Desvoyes B, Adami P, Radom J, Jouvenot M 2000 Cytotoxic activity of a recombinant GnRH-PAP fusion toxin on human tumor cell lines. FEBS Lett 472:241-246
43. Spona J 1975 Some structural requirements for LH-RH actions. Endocrinol Exp 9:159-165
44. Schally AV, Kastin AJ, Coy DH 1976 Edward T. Tyler Prize Oration: LH-releasing hormone and its analogs: recent basic and clinical investigations. Int J Fertil 21:1-30
45. Boepple PA, Mansfield MJ, Wierman ME, Rudlin CR, Bode HH, Crigler JF, Crawford JD, Crowley WF 1986 Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty. Endocr Rev 7:24-33
46. Karten MJ, Rivier JE 1986 Gonadotropin-releasing hormone analog design. Structure-function studies towards the development of agonists and arttagonists: rationale and perspective. Endocr Rev 7:44-66
47. Szoke B, Horvath J, Halmos G, Rekasi Z, Groot K, Nagy A, Schally AV 1994 LH-RH analogue carrying a cytotoxic radical is internalized by rat pituitary cells in vitro. Peptides 15:359-366
48. Hopkins CR, Gregory H 1977 Topographical localization of the receptors for luteinizing hormone releasing hormone on the surface of dissociated pituitary cells. J Cell Biol 75:528-540
49. Fekete M, Wittliff JL, Schally AV 1989 Characteristics and distribution of receptors for [D-TRP6]-luteinizing hormone-releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancer. J Clin Lab Anal 3:137-147
50. Emons G, Schally AV 1994 The use of luteinizing hormone releasing hormone agonists and antagonists in gynaecological cancers. Hum Reprod 9:1364-1379